| Name | Title | Type |
|---|---|---|
| Paul Valentine | Senior Managing Director | Auditee |
| Sharon Walsh | CFO | Auditee |
| Joyce Shannon | President | Auditee |
| Jennifer Corliss | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 408309 | 2025 | 2026-07-31 | BAKER TILLY US LLP | $9.60M |
| 364597 | 2024 | 2025-08-20 | Cliftonlarsonallen LLP | $9.76M |
| 324360 | 2023 | 2024-10-10 | Cliftonlarsonallen LLP | $10.01M |
| 26705 | 2022 | 2023-09-05 | Cliftonlarsonallen LLP | $10.58M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 408309 | 2025 | 2026-07-31 | 1225270 | 2025-005 | Material Weakness | Yes | N |
| 408309 | 2025 | 2026-07-31 | 1225269 | 2025-005 | Material Weakness | Yes | N |
| 408309 | 2025 | 2026-07-31 | 1225268 | 2025-004 | Material Weakness | Yes | N |
| 408309 | 2025 | 2026-07-31 | 1225267 | 2025-004 | Material Weakness | Yes | N |
| 408309 | 2025 | 2026-07-31 | 1225266 | 2025-003 | Material Weakness | Yes | N |
| 408309 | 2025 | 2026-07-31 | 1225265 | 2025-002 | Material Weakness | Yes | N |
| 408309 | 2025 | 2026-07-31 | 1225264 | 2025-002 | Material Weakness | Yes | N |
| 364597 | 2024 | 2025-08-20 | 1150459 | 2024-003 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 1150458 | 2024-003 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 1150457 | 2024-002 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 1150456 | 2024-002 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 574017 | 2024-003 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 574016 | 2024-003 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 574015 | 2024-002 | Significant Deficiency | - | N |
| 364597 | 2024 | 2025-08-20 | 574014 | 2024-002 | Significant Deficiency | - | N |
| 324360 | 2023 | 2024-10-10 | 1078575 | 2023-002 | Significant Deficiency | - | N |
| 324360 | 2023 | 2024-10-10 | 1078574 | 2023-002 | Significant Deficiency | - | N |
| 324360 | 2023 | 2024-10-10 | 502133 | 2023-002 | Significant Deficiency | - | N |
| 324360 | 2023 | 2024-10-10 | 502132 | 2023-002 | Significant Deficiency | - | N |